Extrachromosomal resistance in Gram-negative organisms: the evolution of β-lactamase

作者: George A. Jacoby

DOI: 10.1016/0966-842X(94)90611-4

关键词:

摘要: beta-Lactamases are the major defense used by bacteria to overcome effects of penicillins, cephalosporins and related beta-lactam antibiotics. In antibiotic era, enzymes have evolved become more prevalent, appear in new hosts, be expressed at higher levels, acquired plasmids change catalytic properties increase affinity for what were meant nonhydrolysable substrates or reduce beta-lactamase inhibitors.

参考文章(24)
J Brunton, M Meier, N Erhman, D Clare, R Almawy, Origin of small beta-lactamase-specifying plasmids in Haemophilus species and Neisseria gonorrhoeae. Journal of Bacteriology. ,vol. 168, pp. 374- 379 ,(1986) , 10.1128/JB.168.1.374-379.1986
K Bush, Beta-lactamase inhibitors from laboratory to clinic. Clinical Microbiology Reviews. ,vol. 1, pp. 109- 123 ,(1988) , 10.1128/CMR.1.1.109
R P Ambler, A F W Coulson, J M Frère, J M Ghuysen, B Joris, M Forsman, R C Levesque, G Tiraby, S G Waley, A standard numbering scheme for the class A beta-lactamases. Biochemical Journal. ,vol. 276, pp. 269- 270 ,(1991) , 10.1042/BJ2760269
L B Rice, S H Marshall, L L Carias, L Sutton, G A Jacoby, Sequences of MGH-1, YOU-1, and YOU-2 extended-spectrum beta-lactamase genes. Antimicrobial Agents and Chemotherapy. ,vol. 37, pp. 2760- 2761 ,(1993) , 10.1128/AAC.37.12.2760
Roger C. Levesque, George A. Jacoby, Molecular structure and interrelationships of multiresistance β-lactamase transposons Plasmid. ,vol. 19, pp. 21- 29 ,(1988) , 10.1016/0147-619X(88)90059-5
L B Rice, S H Willey, G A Papanicolaou, A A Medeiros, G M Eliopoulos, R C Moellering, G A Jacoby, Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility. Antimicrobial Agents and Chemotherapy. ,vol. 34, pp. 2193- 2199 ,(1990) , 10.1128/AAC.34.11.2193
J Blazquez, M R Baquero, R Canton, I Alos, F Baquero, Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli. Antimicrobial Agents and Chemotherapy. ,vol. 37, pp. 2059- 2063 ,(1993) , 10.1128/AAC.37.10.2059